Standard BioTools Inc. (NASDAQ:LAB) Q3 2024 Earnings Call Transcript October 30, 2024
Standard BioTools Inc. beats earnings expectations. Reported EPS is $-0.07, expectations were $-0.09.
Operator: Good day and welcome to the Standard BioTools Inc Third Quarter 2024 Financial Results Conference Call. All participants will be in listen-only mode. After today’s presentation, There will be an opportunity to ask questions. [Operator Instructions] Please note, this event is being recorded. I...
